3 minute read
Cardiac VALVE DISEASE
Our multidisciplinary team is a national leader in cardiac valve disease. Our expert minimally invasive and percutaneous heart valve programs were built upon our decades-long reputation for excellence in surgical valve procedures. We our decades-long reputation for excellence in surgical valve procedures.
INTEGRATED HEART TEAM APPROACH for the management of valve disease
Specialized Aortic Surgeons
Specialized Mitral Surgeons
Specialized Interventional Cardiologists
Specialized Cardiac Anesthesiologists
Advanced Heart Failure Specialists
Advanced Practice Providers
RN Clinical Care Coordinators
Clinical Research Team
Quality & Safety Specialists
IMAGING SPECIALISTS:
Echocardiologists
Radiologists
Nuclear Medicine
Imaging Specialists
We offer patients the latest open surgical and percutaneous options for all valve conditions and specialize in the management of cardiac valves over a lifetime.
TRICUSPID VALVE
The Frankel CVC offers the most comprehensive tricuspid valve treatment program in the state founded on excellent outcomes with a breadth of minimally invasive and conventional surgical options.
We are one of the few centers nationally to participate in a broad spectrum of percutaneous repair and replacement clinical trials, providing patients access to next generation technologies, including:
Edge to edge repair
Replacement devices
The TRiCares Topaz Transfemoral Tricuspid Valve Replacement System, a novel system designed to eliminate tricuspid regurgitation, allow the right ventricle to remodel, and minimize the risk for pacemaker.
AORTIC VALVE
We are an internationally recognized leader in aortic valve repair and replacement and have long been at the forefront of aortic valve surgery, including aortic valve insufficiency, stenosis, and repair of aortic root aneurysms.
Today, the Frankel CVC offers patients a variety of minimally invasive treatment options, including cutting edge transcatheter valve replacement techniques for aortic valve disease and the percutaneous treatment of failed bioprosthetic valves. We also offer the latest in dedicated leaflet modification technologies
U-M TAVR TICKER 3,064 AORTIC VALVES REPLACED AND COUNTING
We consistently earn national recognition as “High Performing” in aortic valve repair or replacement by U.S. News & World Report in its annual quality and safety rankings.
Our team developed novel aortic annular enlargement techniques for patients needing surgical aortic valve replacement, to allow larger valve size replacements leading to better blood flow and improved survival.
MITRAL VALVE
As one of the largest and longest-standing mitral valve centers in the country, and the largest in Michigan, the Frankel CVC is nationally recognized for expertise in mitral valve repair and treatment
We were one of the first five medical centers in the U.S. to receive a Mitral Valve Repair Reference Center Award based on our high volume of mitral valve procedures, superior clinical and patient outcomes, and the highest mitral repair rates.
Our mitral valve program offers an extensive range of treatment options that spans traditional approaches as well as minimally invasive surgery (sternal sparing) and percutaneous approaches.
The percutaneous program offers a wide variety of repair and replacement technologies. We are one of few centers in the country to offer AltaValve, a novel transcatheter mitral valve replacement in a pivotal clinical trial to treat severe mitral regurgitation designed to anatomically fit in many more patients than other valves.
NOVEL CLINICAL TRIALS
Through our robust clinical trials program, patients who are not candidates for commercially approved transcatheter and/or surgical therapies have access to a wide variety of alternative treatment options not available at other sites in Michigan.
Currently participating in 16 VALVE CLINICAL TRIALS
TAVR: 5 AORTIC: 2 MITRAL: 6 TRICUSPID: 3
For information about our many active clinical trials, visit UMHealthResearch.org
